Suscribirse

One-session bilateral total knee replacement: Late complications and survivorship - 19/08/20

Doi : 10.1016/j.otsr.2020.02.017 
Yoann Levy, Michel Azar, Antoine Raffaelli, Laurie Tran, Michel Carles, Pascal Boileau, Christophe Trojani
 Institut Universitaire Locomoteur et du sport, Hôpital Pasteur 2, CHU de Nice, 30, voie Romaine, 06000 Nice, France 

Corresponding author at: Service de Chirurgie Orthopédique, Institut Universitaire Locomoteur et du Sport, Hôpital Pasteur 2, CHU de Nice, 30, voie Romaine, 06000 Nice, France.Service de Chirurgie Orthopédique, Institut Universitaire Locomoteur et du Sport, Hôpital Pasteur 2, CHU de Nice30, voie RomaineNice06000France

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Introduction

The early morbidity and mortality of one-session bilateral total knee arthroplasty (1-session BTKA) has been reported in the medical literature. However, there is less information about the long-term clinical impact of this strategy. The aim of this study was to report on the late complications (>90 days), clinical outcomes (KOOS and new KSS) along with the survivorship of 1-session BTKA. We hypothesised that 1-session BTKA will cause few late complications and that the implant survival will meet the criteria of the National Institute for Health and Clinical Excellence (NICE).

Methods

This single-centre retrospective study analysed a cohort of ASA-1 and ASA-2 patients who underwent 1-session BTKR over an 8-year period (2009 to 2016). The cohort consisted of 116 patients (66% women, 34% men) with mean age at inclusion of 69 years (32–85 years); 22% of patients were ASA-1 and 78% were ASA-2. The implant-related, infection-related or mechanical complications that occurred more than 90 days after the operation, the clinical outcomes (KOOS and New KSS) and radiological outcomes, along with the survivorship were determined during the scheduled follow-up visits at 3 months, 6 months and 1 year postoperative and during the long-term follow-up or during an intercurrent event.

Results

No patients were lost to follow-up. Fifteen complications occurred (6.5%): four infections, four patellar problems (three cases of clunk syndrome and one of patellofemoral pain), four cases of stiffness, two of unexplained pain and one femoral periprosthetic fracture. Eight patients were readmitted to the hospital (7%); seven were reoperated (3%) and two implants were revised (1%). The functional outcomes (KOOS and New KSS) were significantly improved and 87% of patients were satisfied or very satisfied with this procedure. At a mean follow-up of 5 years, the survivorship estimated using the Kaplan–Meier method was 98.4% (95% CI: 0.933–0.996).

Conclusion

Performing 1-session BTKA is a reliable strategy as it produces a low rate of late complications, excellent medium-term functional outcomes and survivorship that meets NICE criteria, thus confirming our hypothesis.

Level of evidence

IV, retrospective case series.

El texto completo de este artículo está disponible en PDF.

Keywords : Total knee replacement, One session, Complications, Survival curve


Esquema


© 2020  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 106 - N° 5

P. 903-906 - septembre 2020 Regresar al número
Artículo precedente Artículo precedente
  • Knee surgery trends and projections in France from 2008 to 2070
  • Roger Erivan, Anna Tardieu, Guillaume Villatte, Matthieu Ollivier, Christophe Jacquet, Stéphane Descamps, Stéphane Boisgard
| Artículo siguiente Artículo siguiente
  • Excellent outcomes for lateral unicompartmental knee arthroplasty: Multicenter 268-case series at 5 to 23 years’ follow-up
  • Etienne Deroche, Sébastien Martres, Matthieu Ollivier, Sylvain Gadeyne, Frank Wein, François-Xavier Gunepin, Franck Remy, Roger Badet, Sébastien Lustig, la SFHG

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.